Free Trial

Graybug Vision (GRAY) Competitors

Graybug Vision logo
$1.71 -0.04 (-2.29%)
As of 05/22/2025

GRAY vs. SCNX, CLRB, CSCI, HOTH, BLRX, LSB, DWTX, TLPH, CYCN, and HCWB

Should you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include Scienture (SCNX), Cellectar Biosciences (CLRB), COSCIENS Biopharma (CSCI), Hoth Therapeutics (HOTH), BioLineRx (BLRX), Lakeshore Biopharma (LSB), Dogwood Therapeutics (DWTX), Talphera (TLPH), Cyclerion Therapeutics (CYCN), and HCW Biologics (HCWB). These companies are all part of the "pharmaceutical preparations" industry.

Graybug Vision vs.

Graybug Vision (NASDAQ:GRAY) and Scienture (NASDAQ:SCNX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings, valuation and community ranking.

Scienture has higher revenue and earnings than Graybug Vision.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Graybug VisionN/AN/A-$35.60M-$24.23-0.07
Scienture$146.90K77.23-$17.84MN/AN/A

Graybug Vision received 16 more outperform votes than Scienture when rated by MarketBeat users.

CompanyUnderperformOutperform
Graybug VisionOutperform Votes
16
50.00%
Underperform Votes
16
50.00%
ScientureN/AN/A

Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Scienture has a beta of 2.83, indicating that its share price is 183% more volatile than the S&P 500.

In the previous week, Scienture had 2 more articles in the media than Graybug Vision. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Graybug Vision. Scienture's average media sentiment score of 1.00 beat Graybug Vision's score of 0.00 indicating that Scienture is being referred to more favorably in the news media.

Company Overall Sentiment
Graybug Vision Neutral
Scienture Positive

Scienture's return on equity of -77.60% beat Graybug Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Graybug VisionN/A -77.61% -71.34%
Scienture N/A -77.60%-62.29%

49.9% of Graybug Vision shares are held by institutional investors. Comparatively, 5.7% of Scienture shares are held by institutional investors. 7.9% of Graybug Vision shares are held by company insiders. Comparatively, 49.7% of Scienture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Scienture beats Graybug Vision on 8 of the 10 factors compared between the two stocks.

Get Graybug Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GRAY vs. The Competition

MetricGraybug VisionPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.69M$6.49B$5.33B$8.35B
Dividend YieldN/A2.64%5.20%4.10%
P/E Ratio-0.998.5626.7419.65
Price / SalesN/A258.46394.49119.78
Price / CashN/A65.8538.3234.62
Price / Book1.026.406.744.50
Net Income-$35.60M$143.98M$3.23B$248.32M
7 Day Performance-10.61%0.06%0.13%-0.96%
1 Month Performance12.50%1.81%8.83%10.86%
1 Year Performance-66.86%-0.92%18.45%9.08%

Graybug Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GRAY
Graybug Vision
N/A$1.71
-2.3%
N/A-67.6%$2.69MN/A-0.9927High Trading Volume
SCNX
Scienture
N/A$0.93
-2.2%
N/AN/A$12.17M$136,643.000.00N/ANews Coverage
CLRB
Cellectar Biosciences
2.3115 of 5 stars
$0.26
+1.8%
$12.50
+4,707.7%
-92.1%$11.94MN/A-0.1510Analyst Forecast
CSCI
COSCIENS Biopharma
N/A$3.58
-0.7%
N/AN/A$11.25M$9.59M-0.3020Gap Down
HOTH
Hoth Therapeutics
2.7232 of 5 stars
$0.85
flat
$4.00
+370.6%
-30.0%$11.23MN/A-0.644Analyst Downgrade
BLRX
BioLineRx
1.6337 of 5 stars
$3.37
+3.1%
$26.00
+671.5%
-84.7%$11.22M$28.94M-0.3840Upcoming Earnings
Gap Down
LSB
Lakeshore Biopharma
0.6982 of 5 stars
$1.13
+0.4%
N/AN/A$10.53M$672.27M0.00773Positive News
Gap Up
DWTX
Dogwood Therapeutics
1.1809 of 5 stars
$5.50
-3.8%
$10.00
+82.0%
N/A$10.50MN/A-0.845
TLPH
Talphera
2.7403 of 5 stars
$0.52
+2.4%
$5.00
+857.9%
-50.6%$10.46M$281,000.00-0.7419Gap Down
CYCN
Cyclerion Therapeutics
0.8126 of 5 stars
$3.19
+2.6%
N/A+19.9%$10.29M$2.08M-2.7630
HCWB
HCW Biologics
1.3484 of 5 stars
$8.98
+4.8%
N/A-81.3%$10.22M$2.57M-9.1040Gap Down

Related Companies and Tools


This page (NASDAQ:GRAY) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners